Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.16

€0.16

-7.600%
-0.013
-7.600%
-
 
15:35 / Tradegate WKN: A3DEUD / Name: Hytn Innovations Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Hytn Innovations Inc. Stock

Hytn Innovations Inc. took a tumble today and lost -€0.013 (-7.600%).

Pros and Cons of Hytn Innovations Inc. in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

News

HYTN Successfully Exports GMP-Manufactured Vape Cartridges
HYTN Successfully Exports GMP-Manufactured Vape Cartridges

VANCOUVER, British Columbia, April 30, 2026 -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products

HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business

Vancouver, British Columbia, April 23, 2026 - HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has approved the

HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany

Vancouver, British Columbia, April 17, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products